Medical treatment of uterocutaneous fistula with gonadotropin-releasing hormone agonist administration.
BACKGROUND
Uterocutaneous fistula is a rare complication of uterine surgery. All published cases have been surgically treated with hysterectomy and excision of the fistulous tract. We report a case of uterocutaneous fistula that was successfully treated with gonadotropin-releasing hormone agonist administration.


METHODS
A 25-year-old woman reported bloody discharge during her periods from a previous Pfannenstiel incision. A fistulous tract leading from the incision scar to the uterus was diagnosed. Leuprolide acetate depot was administered twice subcutaneously at a dose of 11.25 mg. The fistulous tract closed spontaneously, and the patient was symptom free thereafter.


CONCLUSIONS
Medical treatment with gonadotropin-releasing hormone agonists should be considered before resorting to surgery for treatment of uterocutaneous fistulae.
Seyhan
Ayse
A
Department of Obstetrics and Gynecology, the American Hospital of Istanbul, Istanbul, Turkish Republic.
Ata
Baris
B
Sidal
Bilhan
B
Urman
Bulent
B
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002585:Cesarean Section / Q000009:adverse effects; D017577:Cutaneous Fistula / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use*; D014591:Uterine Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide